Analyst Reco. Edwards Lifesciences Corporation Xetra

Equities

EWL

US28176E1082

Real-time Estimate Tradegate Other stock markets 06:46:57 17/05/2024 pm IST			5-day change	1st Jan Change
83.59 ^EUR	+0.64%		+2.17%	+19.78%

14/05	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	MT
13/05	Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	14/05	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	14/05	MT
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	07/05	MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	02/05	MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	01/05	MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72	29/04	MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92	26/04	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83	26/04	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94	26/04	MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating	26/04	MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85	26/04	MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86	26/04	MT
Baird Adjusts Edwards Lifesciences Price Target to $102 From $100	17/04	MT
Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating	17/04	MT
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
Zacks Investment Research Adjusts Price Target on Edwards Lifesciences to $95 From $97	15/04	MT
Truist Securities Adjusts Edwards Lifesciences Price Target to $105 From $97, Buy Rating Kept	15/04	MT
RBC Raises Price Target on Edwards Lifesciences to $101 From $95, Keeps Outperform Rating	15/04	MT
Mizuho Securities Adjusts Price Target on Edwards Lifesciences to $105 From $95, Maintains Buy Rating	11/04	MT
Edwards Lifesciences Insider Sold Shares Worth $1,154,142, According to a Recent SEC Filing	09/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 08:55 pm IST